Trial Profile

Effect of naronapride on reflux events as well as oesophageal and gastric pH in patients with gastro-oesophageal reflux

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 20 May 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naronapride (Primary)
Indications Gastro-oesophageal reflux
Focus Pharmacodynamics
Sponsors ARYx Therapeutics

Most Recent Events

20 May 2011 New trial record
10 May 2011 Pharmacodynamic results presented at Digestive Disease Week 2011.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com